Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody - RSC Advances (RSC Publishing)
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells | BMC Cancer | Full Text
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD- L1 Axis - ScienceDirect
Frontiers | A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy
RecombiMAb anti-mouse PD-1 (CD279) (D265A) | Bio X Cell
PD-L1 on dendritic cells controls the antitumor response
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory: Molecular Therapy - Oncolytics
Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load | Scientific Reports
Mouse PD-1 Antibody AF1021: R&D Systems
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance | Nature Immunology
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells | Scientific Reports
Anti-Mouse PD-1 Antibody (RMP1-14), In Vivo Grade | Leinco
Agonistic anti-PD-1 antibodies turn on the immunosuppressive activity of PD- 1
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo | Nature Biotechnology
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells | Scientific Reports
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy - ScienceDirect
Blockade of the PD-1/PD-L1 interaction by the anti-PD-L1 peptides and... | Download Scientific Diagram
PD1 Antibody Selection Tool | Bio X Cell
PD‐1‐specific “Blocking” antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments - Polesso - 2021 - European Journal of Immunology - Wiley Online Library